Tamara Vukosavljevic

Author

Centro di Riferimento Oncologico

Also Known As

T Vukosavljevic, T. Vukosavljevic, Tamara Vukosavljevic

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Centro di Riferimento Oncologico The Ohio State University Cancer Genetics (United States)University of Chicago Wake Forest University

About

Tamara Vukosavljevic is an author at Centro di Riferimento Oncologico specializing in medicine, cancer research, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	626
2	Cell Biology	6	6	443
3	Health Sciences	2	2	42
4	Immunology	2	2	31
5	Diagnostic Sciences	1	1	16

Tamara Vukosavljevic

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Adverse Prognostic Significance of <i>KIT</i> Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study Peter Paschka, Guido Marcucci, Amy S. Ruppert, Journal of Clinical Oncology	2006	660
MicroRNA Expression in Cytogenetically Normal Acute Myeloid Leukemia Guido Marcucci, Michael D. Radmacher, Kati Maharry, New England Journal of Medicine	2008	437
Phase I Study of Decitabine Alone or in Combination With Valproic Acid in Acute Myeloid Leukemia William Blum, Rebecca B. Klisovic, Bjoern Hackanson, Journal of Clinical Oncology	2007	319
Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, <i>CEBPA</i> Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study Guido Marcucci, Kati Maharry, Michael D. Radmacher, Journal of Clinical Oncology	2008	303
High Expression Levels of the <i>ETS</i>-Related Gene, <i>ERG</i>, Predict Adverse Outcome and Improve Molecular Risk-Based Classification of Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Guido Marcucci, Kati Maharry, Susan P. Whitman, Journal of Clinical Oncology	2007	191
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study Christian Langer, Michael D. Radmacher, Amy S. Ruppert, Blood	2008	189
Three discrete regions of deletion at 3p in head and neck cancers. Roberta Maestro, Daniela Gasparotto, Tamara Vukosavljevic, PubMed PathologyEpigeneticsTumor BiologyOncologyDiscrete Regions	1993	163
Overexpression of CDC25A and CDC25B in head and neck cancers. Daniela Gasparotto, Roberta Maestro, Sara Piccinin, PubMed PathologyCell CycleTumor BiologyTranscriptional RegulationCell Regulation	1997	162
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy Susan P. Whitman, Shujun Liu, Tamara Vukosavljevic, Blood	2005	145
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-κB–dependent DNA methyltransferase activity in acute myeloid leukemia Shujun Liu, Zhongfa Liu, Zhiliang Xie, Blood	2007	143

Page 1